News
STAAR Surgical Q2 Earnings Call Highlights
Key Points
- Interested in STAAR Surgical Company? Here are five stocks we like better.
- STAAR Surgical reported a strong second quarter: Net sales more than doubled to $93.5 million, while the
Spero Therapeutics Q2 Earnings Call Highlights
Key Points
- Interested in Spero Therapeutics, Inc.? Here are five stocks we like better.
- Utebzi was approved by the FDA for certain complicated urinary tract infections, with GSK expected to
SKYX Platforms Q2 Earnings Call Highlights
Key Points
- Interested in SKYX Platforms Corp.? Here are five stocks we like better.
- Record Q2 revenue reached $25.3 million, up 14% sequentially and 10% year over year, marking SKYX’s 10th
Sera Prognostics Q2 Earnings Call Highlights
Key Points
- Interested in Sera Prognostics, Inc.? Here are five stocks we like better.
- Revenue remained modest at $30,000 in Q2, up from $17,000 a year earlier, while the net loss widened to $9.1
comScore Q2 Earnings Call Highlights
Key Points
- Interested in comScore, Inc.? Here are five stocks we like better.
- Q2 performance weakened sharply: Revenue fell 11.3% year over year to $79.2 million, while adjusted EBITDA dropped
Red Robin Gourmet Burgers Q2 Earnings Call Highlights
Key Points
- Interested in Red Robin Gourmet Burgers, Inc.? Here are five stocks we like better.
- Comparable sales rose 1.3% in the second quarter, with traffic effectively flat and
RenovoRx Q2 Earnings Call Highlights
Key Points
- Interested in RenovoRx, Inc.? Here are five stocks we like better.
- Record commercial growth: Second-quarter revenue rose 115% year over year to $909,000, supported by increased
Perma-Fix Environmental Services Q2 Earnings Call Highlights
Key Points
- Interested in Perma-Fix Environmental Services, Inc.? Here are five stocks we like better.
- Second-quarter results missed expectations: Revenue fell to $12.9 million from $14.6 million
OptimizeRx Q2 Earnings Call Highlights
Key Points
- Interested in OptimizeRx Corp.? Here are five stocks we like better.
- OptimizeRx’s Q2 revenue fell 30% year over year to $20.5 million, pressured by reduced demand, lower-margin
Carlsmed Eyes Growth as Cervical Launch, Medicare Shift Boost Spine Platform
Key Points
- Interested in Carlsmed, Inc.? Here are five stocks we like better.
- Growth drivers: Carlsmed plans to launch its corra cervical platform in the fourth quarter, with cervical
Omeros Q2 Earnings Call Highlights
Key Points
- Interested in Omeros Corporation? Here are five stocks we like better.
- YARTEMLEA sales surged in its first full quarter, reaching $28.5 million in net sales, up 188% sequentially
Marchex Q2 Earnings Call Highlights
Key Points
- Interested in Marchex, Inc.? Here are five stocks we like better.
- Marchex reported Q2 revenue of $11 million, up from $10.6 million in Q1, and forecast Q3 revenue of $16 million to
Nano Nuclear Energy Q3 Earnings Call Highlights
Key Points
- Interested in Nano Nuclear Energy Inc.? Here are five stocks we like better.
- Kronos licensing advanced: The NRC accepted Nano Nuclear’s construction permit application for review
MaxCyte Q2 Earnings Call Highlights
Key Points
- Interested in MaxCyte, Inc.? Here are five stocks we like better.
- Second-quarter revenue fell 15% year over year to $7.3 million, though results exceeded management’s expectations
Lulu's Fashion Lounge Q2 Earnings Call Highlights
Key Points
- Interested in Lulu's Fashion Lounge Holdings, Inc.? Here are five stocks we like better.
- Revenue fell 17% year over year to $67.8 million, pressured by lower order volume, elevated
Lumexa Imaging Q2 Earnings Call Highlights
Key Points
- Interested in Lumexa Imaging Holdings, Inc.? Here are five stocks we like better.
- Lumexa returned to profitability in Q2: Revenue rose 5.1% year over year to $264.2 million, net
Liftoff Mobile Q2 Earnings Call Highlights
Key Points
- Interested in Liftoff Mobile, Inc.? Here are five stocks we like better.
- Strong second-quarter performance: Revenue increased 35% year over year to $220 million, while adjusted EBITDA
Kura Oncology Q2 Earnings Call Highlights
Key Points
- Interested in Kura Oncology, Inc.? Here are five stocks we like better.
- KOMZIFTI generated $9.1 million in Q2 revenue, with about 115 new patient starts and more than 250
Jack In The Box Q3 Earnings Call Highlights
Key Points
- Interested in Jack In The Box Inc.? Here are five stocks we like better.
- Sales declined 1.1% year over year in fiscal Q3 as lower transactions outweighed menu price increases; weak
Inovio Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Inovio Pharmaceuticals, Inc.? Here are five stocks we like better.
- INO-3107’s FDA review is nearing completion, with late-cycle review and pre-licensure inspections
Harmonic Q2 Earnings Call Highlights
Key Points
- Interested in Harmonic Inc.? Here are five stocks we like better.
- Broadband growth exceeded expectations: Second-quarter broadband revenue rose 54% year over year to $133.5 million
Grocery Outlet Q2 Earnings Call Highlights
Key Points
- Interested in Grocery Outlet Holding Corp.? Here are five stocks we like better.
- Second-quarter results exceeded expectations: Net sales rose 1% to $1.19 billion, while
Fossil Group Q2 Earnings Call Highlights
Key Points
- Interested in Fossil Group, Inc.? Here are five stocks we like better.
- Fossil’s Q2 sales fell 4% to $211 million, but exceeded expectations as its turnaround progressed. Gross
Compared to Estimates, Pan American Silver (PAAS) Q2 Earnings: A Look at Key Metrics
For the quarter ended June 2026, Pan American Silver (PAAS) reported revenue of $1.12 billion, up 38.4% over the same period last year. EPS came in at $0.73, compared to $0.43 in the year-ago
Q2 Earnings Scorecard: Record Margins, Strong Beats, and Upward Revisions
Note: The following is an excerpt from this week’s Earnings Trends report. You can access the full report that contains detailed historical actual and estimates for the current and following